PROSPER-SMALL研究PPT课件.pptVIP

PURSUITImpact on myocardial muscle preservation * PURSUITPlatelet IIb-IIIa in Unstable angina:Receptor Suppression Using Integrilin? (eptifibatide) Therapy PURSUIT Death or MI composite within 30 days % Patients with composite events 16.2% 12.8% Angiography within 72 hrs 3.4% ?(p=0.005*) 16.8% 11.8% 5.5% 1.8% 33.5% 18.4% PCIwithin 72 hrs 5.0% ?(p=0.01*) MI prior to PCIwithin 72 hrs 3.7% ?(p=0.001*) CABGwithin 72 hrs 15.1% ?(p=0.001*) * Post-randomization analysis PURSUIT Death or MI composite at 30 days in patients undergoing PCI within 2, 4, or 6 hours of randomization % Pat